JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitaker, J. M.
Right arrow Articles by Barbosa, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitaker, J. M.
Right arrow Articles by Barbosa, P.
Journal of the American Podiatric Medical Association Volume 91 Number 2 79-84 2001
Copyright © 2001 American Podiatric Medical Association

Plantar Verrucae in Patients with Human Immunodeficiency Virus

Clinical Presentation and Treatment Response

Jeffrey M. Whitaker, BS*, Geoffrey L. Gaggero, DPM{dagger}, Lacey Loveland, DPM{ddagger}, Lolita Segura§ and Peter Barbosa, PhD||

* Submitted during second year, California College of Podiatric Medicine, San Francisco.
{dagger} Submitted during third year, California College of Podiatric Medicine, San Francisco.
{ddagger} Submitted during second-year residency, California College of Podiatric Medicine, San Francisco.
§ Research Coordinator, California College of Podiatric Medicine, San Francisco.
|| Associate Professor of Microbiology and Immunology, California College of Podiatric Medicine, San Francisco. Mailing address: 4150 17th St, #1, San Francisco, CA 94114.

Abstract

Several previous studies have yielded data showing that plantar and other cutaneous verrucae follow a more aggressive course in patients infected with human immunodeficiency virus (HIV) than in uninfected individuals. A pilot study was undertaken to identify trends in a sample population that would support this characterization of plantar verrucae in HIV+ patients and to determine whether there are differences in treatment response between HIV+ and HIV- patients. The results show that the HIV+ patients in the study presented with a significantly greater number and total area of lesions than did the HIV- patients. Furthermore, the HIV+ patients experienced a greater frequency of recurrence of their lesions following treatment with surgical curettage. These findings should provide the foundation for other extensive, multicenter studies to further characterize the treatment response of these lesions in HIV+ patients and to develop effective guidelines for their management. (J Am Podiatr Med Assoc 91(2): 79-84, 2001)






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Podiatric Medical Association.